Medtronic (MDT) Tops Q2 EPS by 3c; Nudges FY16 EPS Midpoint Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $98.88 --0%
Revenue Growth %: +5.3%
Financial Fact:
Provision for income taxes: 217M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +5.3%
Financial Fact:
Provision for income taxes: 217M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q2 EPS of $1.03, $0.03 better than the analyst estimate of $1.00. Revenue for the quarter came in at $7.1 million versus the consensus estimate of $7.06 million.
GUIDANCE:
Medtronic sees FY16 EPS of $4.33-$4.40, versus prior guidance of $4.30-$4.40 and the consensus of $4.36.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
